Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

External Validation of Uromonitor as a Biomarker for Optimization of NMIBC Management by the CUETO Group

NCT05864599 is registered in ClinicalTrials.gov with Pharmalink as lead sponsor.

NCT NCT05864599
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05864599 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
External Validation of Uromonitor as a Biomarker for Optimization of NMIBC Management by the CUETO Group
Lead sponsor
Pharmalink
Phase
Observational
Overall status
Unknown status
Start date
June 16, 2023
Completion date
June 30, 2024
Enrollment
600 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non-muscle-invasive bladder cancer